Orbimed Advisors LLC Kinnate Biopharma Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.33 - $6.84 $6.68 Million - $19.6 Million	2,866,100 Added 55.72%	8,009,729 $24.3 Million
Q1 2023 May 15, 2023	BUY	$3.46 - $7.98 $3.81 Million - $8.78 Million	1,100,000 Added 27.2%	5,143,629 $32.1 Million
Q1 2022 May 16, 2022	BUY	$7.73 - $17.99 $1.51 Million - $3.52 Million	195,700 Added 5.09%	4,043,629 $45.5 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $140 Million - $174 Million	3,847,929 New	3,847,929 $153 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.